Delivery Order 75N95024D00002-75N98026F00001

Award Date 2/1/24

Potential Completion Date 9/29/27

Potential Value $124K

Funding Federal Agency

National Institute on Aging

Contracting Federal Agency

Office of Logisitics and Acquisition Operations

Awardee

University Of Exeter ZNQ1VJLJQ827

Ultimate Awardee

Not listed

NAICS Category

541990 - All Other Professional, Scientific, and Technical Services

PSC Category

B504 - Special Studies/Analysis- Chemical/Biological

Set-Aside Type

No Set-Aside Used

Federal Contract Vehicle

Not listed

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Cost No Fee

Place of Performance

Great Britain, United Kingdom

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The National Institute on Aging issued a delivery order to the University of Exeter on February 1, 2024, with a ceiling value of $123,504.44 under a single-award indefinite delivery contract for clinical evaluation of phenserine tartrate extended-release formulation in early mild Alzheimer's disease and mild to moderate traumatic brain injury.

The parent IDV, valued at $1,988,692 and awarded in February 2024, enables the National Institute on Aging to issue task orders for clinical evaluation services related to Alzheimer's disease and traumatic brain injury research over a 30-month period. The University of Exeter conducts clinical trials, brain imaging, cognitive assessments, and biomarker analysis to evaluate investigational drug treatments. Place of performance is Great Britain, United Kingdom. The order is priced on a cost-no-fee basis. Ultimate completion is scheduled for September 29, 2027.

Generated 9/26/26, 9:42 AM

Mod #	Description	ReasonForModification	Federal Obligation	Date
Not listed		Not listed	$123.5k	9/25/26